Patents by Inventor B. Reddy

B. Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030083581
    Abstract: A method of automatically selecting a physiological data manipulation process. After raw data including an asynchronous component having diagnostic information and including a synchronous component is received, the asynchronous component is separated from the synchronous component. A data manipulation process based on the diagnostic information is automatically selected based on the signal conditions generated during an analysis process.
    Type: Application
    Filed: October 25, 2001
    Publication date: May 1, 2003
    Inventors: Basel H. Taha, Shankara B. Reddy, Joel Q. Xue, Paul P. Elko
  • Publication number: 20030073914
    Abstract: A method and apparatus for performing serial comparison between electrocardiograms (ECGs) acquired from a patient. The method includes acquiring ECGs from a patient with an acquisition device and using the acquisition device to perform a serial comparison between at least two of the acquired ECGs. The apparatus is an acquisition device including an acquisition module for acquiring ECGs from a patient and a signal processor for performing a serial comparison between at least two of the acquired ECGs.
    Type: Application
    Filed: October 11, 2001
    Publication date: April 17, 2003
    Inventors: Basel H. Taha, Shankara B. Reddy, Joel Q. Xue
  • Publication number: 20030059898
    Abstract: Biologically active heteropolymeric protein composed of a plurality of subunits, both subunits being synthesized in a single cell having an expression vector comprising heterologous DNA encoding the subunits. Preferably the protein is similar to the human or ungulate fertility hormones, LH and FSH.
    Type: Application
    Filed: August 26, 2002
    Publication date: March 27, 2003
    Applicant: Genzyme Corporation
    Inventors: Anton Beck, Edward Bernstine, Nancy Hsiung, Vermuni B. Reddy
  • Patent number: 6534435
    Abstract: The present invention relates to a process for the in situ synthesis of acid or cationic form of heteropolyacid of molybdenum or tungsten due to the interaction of the cationic compound with the acidic or salt form of Mo or W and the phosphate ion of a solid support.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: March 18, 2003
    Assignee: Council of Scientific and Industrial Research
    Inventors: Potharaju S. S. Prasad, Kondapuram V. Raghavan, Iragavarapu Suryanarayana, Katabathini N. Rao, Srilakshmi Chilukoti, Matam S. Kumar, Kommasami B. Reddy
  • Publication number: 20030028119
    Abstract: A method of displaying a representation of a physiological signal produced by a patient. The method includes the acts of obtaining a portion of at least one physiological signal acquired from the patient, determining an area to display, and constructing a virtual image representing at least a portion of the patient. The virtual image including (M) polygonal areas. The method further includes transforming the obtained signal to a plurality of values, assigning each value to one of the (M) polygonal areas, assigning a visual characteristic to each polygonal area based in part on the assigned values, and displaying at least a portion of the virtual image including the assigned visual characteristics. The invention further provides a method of optimal feature selection for the classification of the physiological signals produced by a patient.
    Type: Application
    Filed: August 6, 2001
    Publication date: February 6, 2003
    Inventors: Joel Q. Xue, Shankara B. Reddy
  • Patent number: 6479970
    Abstract: An un-interruptible power supply coupled to a dc input voltage node, having a mode control circuit to monitors the input voltage and to provide a mode selection signal to indicate that the input voltage is above a predetermined level. A high frequency transformer has a primary winding, an output winding and a charger winding. A battery is referenced to a third reference potential node. An input inverter transfers power from the dc input voltage to an output rectifier and to an adaptive converter to charge a battery. The output rectifier and filter provides the output dc voltage referenced to the second reference potential node. The adaptive converter referenced to the third reference potential transfer power from the battery to the transformer charger winding to provide the output dc voltage source.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: November 12, 2002
    Inventor: Anantha B. Reddy
  • Patent number: 6463320
    Abstract: An apparatus and a method for taking multiple physiological signals (e.g., ECG waveforms) from different sources as input, applying multiple algorithms in its core and generating results which are exported for use in clinical studies and research. The apparatus has a built-in database and a built-in spreadsheet to provide a unified platform for all clinical research in the medical field, including, but not limited to, clinical core laboratory work and high-end clinical research.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: October 8, 2002
    Assignee: GE Medical Systems Information Technologies, Inc.
    Inventors: Qiuzhen Xue, Shankara B. Reddy
  • Publication number: 20020140403
    Abstract: An un-interruptible power supply coupled to a dc input voltage node, having a mode control circuit to monitors the input voltage and to provide a mode selection signal to indicate that the input voltage is above a predetermined level. A high frequency transformer has a primary winding, an output winding and a charger winding. A battery is referenced to a third reference potential node. An input inverter transfers power from the dc input voltage to an output rectifier and to an adaptive converter to charge a battery. The output rectifier and filter provides the output dc voltage referenced to the second reference potential node. The adaptive converter referenced to the third reference potential transfer power from the battery to the transformer charger winding to provide the output dc voltage source.
    Type: Application
    Filed: April 3, 2001
    Publication date: October 3, 2002
    Inventor: Anantha B. Reddy
  • Patent number: 6455282
    Abstract: Biologically active heteropolymeric protein composed of a plurality of subunits, both subunits being synthesized in a single cell having an expression vector comprising heterologous DNA encoding the subunits. Preferably the protein is similar to the human or ungulate fertility hormones, LH and FSH.
    Type: Grant
    Filed: November 2, 1992
    Date of Patent: September 24, 2002
    Assignee: Genzyme Corporation
    Inventors: Anton Beck, Edward Bernstine, Nancy Hsiung, Vermuni B. Reddy
  • Patent number: 6295176
    Abstract: A memory medium has a plurality of tracks arranged in a plurality of sectors with each track sector having a format which does not include header fields identifying sectors or sector defects or defect management procedures. Track management apparatus identifies the track sector currently confronting a transducer; the track management being based on sector pulses (in the case of a dedicated servo system), or being calculated based on track information, an index pulse and data wedge information from previous wedges (in the case of embedded servo systems), or being derived from a lookup table. To accommodate sector defects, a defect bank contains the identity and type of each defective or spare sector.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: September 25, 2001
    Inventors: Prafulla B. Reddy, Jimmie R. Shaver, Sean R. Atsatt, Mark H. Groo, Timothy V. Gates, William K. Weberg
  • Patent number: 6100089
    Abstract: A rapid, sensitive, and quantitative method and assay system using transgenic animal cells and adult or embryonic transgenic animals to rapidly screen compounds for mutagenic or teratogenic activity. Each cell from a cell culture, a differentiated tissue from an animal or an animal embryo contains a target gene and a reporter gene, both including an animal promoter/enhancer, a coding sequence and a transcription termination signal, so that they are capable of expression in animal cells. The product of the target gene is capable of regulating expression of the reporter gene through interaction with a regulatory sequence in the reporter gene. In the preferred embodiment, the target gene lacI (lac repressor) is coupled to the reporter gene lacZ encoding beta-galactosidase, which is easily detectable by cytochemical or histochemical procedures.
    Type: Grant
    Filed: April 19, 1993
    Date of Patent: August 8, 2000
    Assignee: Exemplar Corporation
    Inventors: Vermuri B. Reddy, Cha-Mer Wei
  • Patent number: 5856137
    Abstract: Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 5, 1999
    Assignee: Genzyme Corporation
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward George Berstine
  • Patent number: 5818654
    Abstract: A memory medium has a plurality of tracks arranged in a plurality of sectors with each track sector having a format which does not include header fields identifying sectors or sector defects or defect management procedures. Track management apparatus identifies the track sector currently confronting a transducer; the track management being based on sector pulses (in the case of a dedicated servo system), or being calculated based on track information, an index pulse and data wedge information from previous wedges (in the case of embedded servo systems), or being derived from a lookup table. To accommodate sector defects, a defect bank contains the identity and type of each defective or spare sector.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: October 6, 1998
    Assignee: Seagate Technology, Inc.
    Inventors: Prafulla B. Reddy, Jimmie R. Shaver, Sean R. Atsatt, Mark H. Groo, Timothy V. Gates, William K. Weberg
  • Patent number: 5767251
    Abstract: Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
    Type: Grant
    Filed: January 22, 1993
    Date of Patent: June 16, 1998
    Assignee: Genzyme Corporation
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward George Bernstine
  • Patent number: 5639640
    Abstract: The correct sequence is disclosed for the beta subunit of human follicle stimulating hormone which, when present in a recombinant heterodimeric human fertility hormone allows the production of biologically active hormone. DNA coding for such beta subunit of human FSH may thus be prepared as well as expression vectors containing such DNA and cells transfected therewith.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 17, 1997
    Assignee: Genzyme Corporation
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward George Bernstine
  • Patent number: 5639639
    Abstract: Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: June 17, 1997
    Assignee: Genzyme Corporation
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward George Bemstine
  • Patent number: 5618318
    Abstract: A high density cell stack is provided utilizing strips of flexible cathode material and flexible anode materials folded over each other at right angles. A suitable anode material is lithium and a suitable cathode material is manganese dioxide. The disclosed cell stacks are rapidly manufactured to provide high density cells with good mechanical stability and good stability against shorting.
    Type: Grant
    Filed: March 12, 1996
    Date of Patent: April 8, 1997
    Assignee: Power Conversion, Inc.
    Inventors: Thomas B. Reddy, Pedro Rodriquez
  • Patent number: 5604131
    Abstract: A nucleic acid construct is described which when expressed in cells, results in the production of APP695, APP751 and APP770. The construct is the cDNA for APP770 with the genomic sequences encoding the KI and OX-2 regions substituting for those regions present in the cDNA.
    Type: Grant
    Filed: September 17, 1993
    Date of Patent: February 18, 1997
    Assignee: Athena Neurosciences, Inc.
    Inventors: Samuel Wadsworth, Benjamin Snyder, Vermuri B. Reddy, Chamer Wei
  • Patent number: 5582768
    Abstract: Electroluminescent phosphors having substantially increased luminance and maintenance over that of prior art electroluminescent phosphors may be made by (1) doping an inorganic intercalation compound having an atomic structure interspersed with vacant spaces, with selected activator ions capable of luminescent emission, and (2) introducing organic monomers or other conductive material into the vacant spaces of the atomic structure of the doped inorganic intercalation compound. The organic monomers may be polymerized in situ to form conductive polymers therein.
    Type: Grant
    Filed: October 24, 1995
    Date of Patent: December 10, 1996
    Assignee: Osram Sylvania, Inc.
    Inventors: Vaddi B. Reddy, Ronald E. Karam, Shellie K. Northrop
  • Patent number: 5567351
    Abstract: Inorganic intercalation phosphors were made by doping an inorganic intercalation compound having an atomic structure interspersed with vacant spaces with selected activator ions capable of luminescent emission when excited by ultraviolet light and/or cathode rays.
    Type: Grant
    Filed: April 20, 1995
    Date of Patent: October 22, 1996
    Assignee: OSRAM Sylvania Inc.
    Inventors: Ru-Yi Qi, Ronald E. Karam, Vaddi B. Reddy, James R. Cox